Capacity and workforce pressures in the NHS can limit equal uptake of innovative treatments if not factored into planning. Advance Product Notification (APN) helps pharma companies share budget and pathway impact data before marketing authorization, enabling NHS payers to plan ahead. IQVIA’s APN Service supports compliance, risk assessment, budget impact modelling, and material development, ensuring effective pre-launch engagement. With access to a large NHS network, IQVIA’s infield market access teams deliver messages at scale and provide local insights, giving brand teams confidence in preparing systems for effective launches.

Join for free to read